Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/1/2667
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yadav, Devendra | - |
dc.date.accessioned | 2018-05-10T09:07:12Z | - |
dc.date.available | 2018-05-10T09:07:12Z | - |
dc.date.issued | 2018 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/1/2667 | - |
dc.description | 103p. | en_US |
dc.language.iso | en | en_US |
dc.publisher | IIPA, New Delhi | en_US |
dc.title | Indian pharmaceutical industry - implications of TRIPS agreement | en_US |
dc.type | Thesis | en_US |
Appears in Collections: | 43rd APPPA (2017-2018) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Devendra Yadav.pdf | 66.88 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.